Dr. Jayne S. Gurtler, MD

Dr. Gurtler practices at Touro Infirmary in New Orleans, Louisiana, part of LCMC Health.

Dr. Gurtler's NPI, 1396712808, was assigned on March 2, 2006. Dr. Gurtler graduated from Tulane University School of Medicine in 1974. Dr. Gurtler holds Louisiana license L012803.

Dr. Gurtler's primary practice is Touro Infirmary, at 1401 Foucher Street, New Orleans, LA 70115 in Orleans Parish. The practice phone is (504) 897-8247.

Dr. Gurtler's primary practice is Touro Infirmary in New Orleans, Louisiana, part of LCMC Health. Dr. Gurtler is also affiliated with East Jefferson General Hospital. The medical group on file is Crescent City Physicians, Inc. Dmand AI also links Dr. Gurtler to 1 more hospital, 1 clinical lab, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gurtler practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Gurtler's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Gurtler is licensed in Louisiana.

CMS data shows 726 Medicare services from Dr. Gurtler across 3 procedure codes in 2024, all of them office visits, for 258 Medicare patients. Medicare paid $53,296 for them. Every service was in an office.

CMS counts 258 Medicare patients who saw Dr. Gurtler in 2024. The largest group is 65 to 74, with 111 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gurtler's median patient age at 74, with 65% women.

In 2024, Dr. Gurtler wrote 1,212 Medicare Part D claims for 210 patients. 68% of them were for generic drugs. CMS names the drug for 873 of them, across 30 drugs with 11 or more claims each, at $3,765,898 in total drug cost. In 2023, CMS named 895 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 76 out of 100 for Dr. Gurtler for performance year 2024, reported as part of a group. Dr. Gurtler accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Gurtler, published from 2011 to 2022. 2014 was the busiest year, with 2. The most frequent topics are Antibodies, Monoclonal and Antibodies, Monoclonal, Humanized. Dr. Gurtler's most frequent co-authors are Benjamin Olney Anderson, Aditya Bardia, MD and Shailender Bhatia, MD.

Dmand AI links Dr. Gurtler to 6 clinical trials, 2 of them phase 1 studies. Conditions studied include Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis and Carcinoma, Bronchogenic. EMD Serono Research & Development Institute, Inc. sponsors the most, 4.

CMS Open Payments shows 110 general payments to Dr. Gurtler from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 75% of the total. Pfizer Inc. paid the most, $508.

Dr. Gurtler graduated from Tulane University School of Medicine in 1974.